Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic lymphocytic leukemia
Pharma
BeiGene's Brukinsa surpasses AZ’s Calquence in quarterly sales
CEO John Oyler compared BeiGene's potential in CLL to two other legendary Big Biotech stories—Gilead in HIV and Vertex in cystic fibrosis.
Angus Liu
Feb 27, 2025 10:56am
ASH: Lilly defends survival data blemish in novel BTK trial win
Dec 9, 2024 5:45pm
AbbVie CLL survey shows emotional impact on patients of color
Dec 9, 2024 11:48am
ASH: AstraZeneca proposes fixed-duration Calquence combos in CLL
Dec 8, 2024 11:00am
BeiGene pushes biomarker testing before treatment for CLL
Dec 4, 2024 6:00am
AstraZeneca trumpets new Calquence combos in CLL
Jul 29, 2024 10:25am
